The association between retinol-binding protein 4 and risk of type 2 diabetes: A systematic review and meta-analysis

References

• Berry DC, Jin H, Majumdar A, Noy N. 2011. Signaling by vitamin a and retinol-binding protein regulates gene expression to inhibit insulin responses. P Natl Acad Sci USA. 108(11):4340–4345. English. doi:10.1073/pnas.1011115108.
   PubMed Web of Science ®Google Scholar
• Broch M, Vendrell J, Ricart W, Richart C, Fernandez-Real JM. 2007. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care. 30(7):1802–1806. doi:10.2337/dc06-2034.
   PubMed Web of Science ®Google Scholar
• Chavez AO, Coletta DK, Kamath S, Cromack DT, Monroy A, Folli F, DeFronzo RA, Tripathy D. 2009. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans. Am J Physiol-Endoc M. 296(4):E758–764. English. doi:10.1152/ajpendo.90737.2008.
   PubMed Web of Science ®Google Scholar
• Cho NH, Ku EJ, Jung KY, Oh TJ, Kwak SH, Moon JH, Park KS, Jang HC, Kim YJ, Choi SH. 2020. Estimated association between Cytokines and the progression to diabetes: 10-year follow-up from a community-based cohort. J Clin Endocrinol Metab. 105(3):e381–389. doi:10.1210/clinem/dgz171.
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, Huang Y, Jd DRF, Ohlrogge AW, Malanda B. 2018. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 138:271–281. doi:10.1016/j.diabres.2018.02.023.
   PubMed Web of Science ®Google Scholar
• Christou GA, Tselepis AD, Kiortsis DN. 2012. The metabolic role of retinol binding protein 4: an update. Horm Metab Res. 44(1):6–14. English. doi:10.1055/s-0031-1295491.
   PubMed Web of Science ®Google Scholar
• Craig RL, Chu WS, Elbein SC. 2007. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol Genet Metab. 90(3):338–344. English. doi:10.1016/j.ymgme.2006.11.003.
   PubMed Web of Science ®Google Scholar
• Fan J, Yin S, Lin D, Liu Y, Chen N, Bai X, Ke Q, Shen J, You L, Lin X, et al. 2019. Association of serum retinol-binding protein 4 levels and the risk of incident type 2 diabetes in subjects with prediabetes. Diabetes Care. 42(8):1574–1581. doi:10.2337/dc19-0265.
   PubMed Web of Science ®Google Scholar
• Graham TE, Wason CJ, Bluher M, Kahn BB. 2007. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia. 50(4):814–823. English. doi:10.1007/s00125-006-0557-0.
   PubMed Web of Science ®Google Scholar
• Hartling L, Milne A, Hamm MP, Vandermeer B, Ansari M, Tsertsvadze A, Dryden DM. 2013. Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers. J Clin Epidemiol. 66(9):982–993. English. doi:10.1016/j.jclinepi.2013.03.003.
   PubMed Web of Science ®Google Scholar
• Jagannathan R, Snehalatha C, Selvam S, Nanditha A, Shetty AS, Godsland IF, Johnston DG, Ramachandran A. 2015. Retinol binding protein-4 predicts incident diabetes in Asian Indian men with prediabetes. Biofactors. 41(3):160–165. doi:10.1002/biof.1209.
   PubMed Web of Science ®Google Scholar
• Kaess BM, Enserro DM, McManus DD, Xanthakis V, Chen MH, Sullivan LM, Ingram C, O’donnell CJ, Keaney JF, Vasan RS, et al. 2012. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham heart study. J Clin Endocrinol Metab. 97(10):E1943–1947. doi:10.1210/jc.2012-1458.
   PubMed Web of Science ®Google Scholar
• Kotnik P, Fischer-Posovszky P, Wabitsch M. 2011. RBP4: a controversial adipokine. Eur J Endocrinol. 165(5):703–711. English. doi:10.1530/EJE-11-0431.
   PubMed Web of Science ®Google Scholar
• Luft VC, Pereira M, Pankow JS, Ballantyne C, Couper D, Heiss G, Duncan BB, Investigators A. 2013. Retinol binding protein 4 and incident diabetes–the atherosclerosis risk in communities study (ARIC Study). Rev Bras Epidemiol = Braz J Epidemiol. 16(2):388–397. doi:10.1590/S1415-790X2013000200014.
   PubMedGoogle Scholar
• Meisinger C, Ruckert IM, Rathmann W, Doring A, Thorand B, Huth C, Kowall B, Koenig W. 2011. Retinol-binding protein 4 is associated with prediabetes in adults from the general population the cooperative health research in the region of Augsburg (KORA) F4 study. Diabetes Care. 34(7):1648–1650. English. doi:10.2337/dc11-0118.
   PubMed Web of Science ®Google Scholar
• Newcomer ME, Ong DE. 2000. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta. 1482(1–2):57–64. doi:10.1016/S0167-4838(00)00150-3.
   PubMedGoogle Scholar
• Norseen J, Hosooka T, Hammarstedt A, Yore MM, Kant S, Aryal P, Kiernan UA, Phillips DA, Maruyama H, Kraus BJ, et al. 2012. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory Cytokines in Macrophages through a c-Jun N-Terminal Kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol. 32(10):2010–2019. English. doi:10.1128/MCB.06193-11.
   PubMed Web of Science ®Google Scholar
• Olsen T, Blomhoff R. 2020. Retinol, Retinoic Acid, and Retinol-Binding Protein 4 are differentially associated with Cardiovascular disease, type 2 diabetes, and obesity: an overview of human studies. Adv Nutr. 11(3):644–666. English. doi:10.1093/advances/nmz131.
   PubMed Web of Science ®Google Scholar
• Palmer AK, Gustafson B, Kirkland JL, Smith U. 2019. Cellular senescence: at the nexus between ageing and diabetes. Diabetologia. 62(10):1835–1841. English. doi:10.1007/s00125-019-4934-x.
   PubMed Web of Science ®Google Scholar
• Pandey GK, Balasubramanyam J, Balakumar M, Deepa M, Anjana RM, Abhijit S, Kaviya A, Velmurugan K, Miranda P, Balasubramanyam M, et al. 2015. Altered circulating levels of retinol binding protein 4 and transthyretin in relation to insulin resistance, obesity, and glucose intolerance in Asian Indians. Endocr Pract. 21(8):861–869. doi:10.4158/EP14558.OR.
   PubMed Web of Science ®Google Scholar
• Quadro L, Hamberger L, Colantuoni V, Gottesman ME, Blaner WS. 2003. Understanding the physiological role of retinol-binding protein in vitamin a metabolism using transgenic and knockout mouse models. Mol Aspects Med. 24(6):421–430. English. doi:10.1016/S0098-2997(03)00038-4.
   PubMed Web of Science ®Google Scholar
• Ramin S, Gharebaghi R, Heidary F. 2015. Scientometric analysis and mapping of scientific articles on diabetic retinopathy. Med Hypothesis Discov Innov Ophthalmol. 4(3):81–100.
   PubMedGoogle Scholar
• Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P. 2009. Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes. 58(1):54–60. doi:10.2337/db08-1019.
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. 2019. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas 9(th) Diabetes Res Clin Pract. 157: 107843. 10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, Unwin N, Wild SH, Williams R 2020. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the international diabetes federation diabetes atlas. 9(th) Diabetes Res Clin Pract. 162: 108086. 10.1016/j.diabres.2020.108086
   PubMed Web of Science ®Google Scholar
• Suh JB, Kim SM, Cho GJ, Choi KM, Han JH, Taek Geun H. 2010. Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women. Metabolism. 59(1):118–122. doi:10.1016/j.metabol.2009.06.025.
   PubMed Web of Science ®Google Scholar
• Sun L, Qi Q, Zong G, Ye X, Li H, Liu X, Zheng H, Hu FB, Liu Y, Lin X. 2014. Elevated plasma retinol-binding protein 4 is associated with increased risk of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr. 144(5):722–728. doi:10.3945/jn.113.189860.
   PubMed Web of Science ®Google Scholar
• Sun Q, Rm VD, Meigs JB, Franco OH, Mantzoros CS, Hu FB. 2010. Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes. 59(3):611–618. doi:10.2337/db09-1343.
   PubMed Web of Science ®Google Scholar
• Ulgen F, Herder C, Kuhn MC, Willenberg HS, Schott M, Scherbaum WA, Schinner S. 2010. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Arch Physiol Biochem. 116(2):57–62. doi:10.3109/13813451003631421.
   PubMedGoogle Scholar
• Veelen A, Tapia EE, Oscarsson J, Schrauwen P. 2020. Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: a step towards personalized diabetes treatment? Mol Metab. 46:101158. doi:10.1016/j.molmet.2020.101158.
   PubMed Web of Science ®Google Scholar
• von Eynatten M, Humpet PM. 2008. Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Rev Mol Diagn. 8(3):289–299. English. doi:10.1586/14737159.8.3.289.
   PubMed Web of Science ®Google Scholar
• Wang Y, Koh WP, Sim X, Yuan JM, Pan A. 2020. Multiple biomarkers improved prediction for the Risk of Type 2 diabetes mellitus in Singapore Chinese men and women. Diabetes Metab J. 44(2):295–306. doi:10.4093/dmj.2019.0020.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun L, Lin X, Yuan J-M, Koh W-P, Pan A. 2019. Retinol binding protein 4 and risk of type 2 diabetes in Singapore Chinese men and women: a nested case-control study. Nutr Metab. 16(1): doi:10.1186/s12986-018-0329-0.
   Google Scholar
• Xu M, Li XY, Wang JG, Wang XJ, Huang Y, Cheng Q, Huang HE, Li R, Xiang J, Tan JR, et al. 2009. Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population. Diabetologia. 52(8):1511–1519. doi:10.1007/s00125-009-1386-8.
   PubMed Web of Science ®Google Scholar
• Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 436(7049):356–362. doi:10.1038/nature03711.
   PubMed Web of Science ®Google Scholar
• Zhang L, Cheng YL, Xue S, Xu ZG. 2020. The role of circulating RBP4 in the Type 2 diabetes patients with kidney diseases: a systematic review and meta-analysis [review]. Dis Markers. 2020:8830471. eCollection 8832020. doi:10.1155/2020/8830471.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Chen H, Ju H, Sun M. 2017. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis [meta-analysis review systematic review]. Lipids Health Dis. 16(1):180. doi:10.1186/s12944-017-0566-7.
   PubMed Web of Science ®Google Scholar